Opko Health OPK
NASDAQ OPK
$1.73 +0.04 (+2.41%)
As of: Sep 22, 2026 · 10:07 AM EDT

Opko Health (OPK) Income from Discontinued Operations (2010 - 2012)

Opko Health's (OPK) quarterly Income from Discontinued Operations came in at -$74000.0 in Q4 2012, down 100.92% on a YoY basis from $8.0 million in Q1 2012, and down 140.44% quarter-over-quarter from $183000.0 in Q3 2012.

Analysis

Opko Health (OPK) Income from Discontinued Operations (2010 - 2012) Analysis & Trends

Opko Health (OPK) has reported Income from Discontinued Operations for 3 consecutive years, with -$74000.0 the latest figure, recorded in Q4 2012.

  • For the quarter ending Q4 2012, Income from Discontinued Operations fell 100.92% year-over-year to -$74000.0; the trailing twelve-month figure through Dec 2013 stood at $109000.0 (down 98.36% YoY), and the FY2012 full-year result was $109000.0, down 97.9% from the prior year.
  • Income from Discontinued Operations slipped to -$74000.0 in Q4 2012 per OPK's latest filing, from $183000.0 in the prior quarter.
  • Across five years, Income from Discontinued Operations topped out at $8.0 million in Q4 2011 and bottomed at -$2.5 million in Q3 2010.
  • Historically, Income from Discontinued Operations has averaged $122500.0 across 3 years, with a median of -$677000.0 in 2011.
  • The sharpest annual moves came in 2011 and 2012: Income from Discontinued Operations jumped 548.66% in 2011, then sank 100.92% in 2012.
  • Over 3 years, Income from Discontinued Operations stood at -$1.8 million in 2010, then surged by 548.66% to $8.0 million in 2011, then slumped by 100.92% to -$74000.0 in 2012.
  • According to Business Quant data, Income from Discontinued Operations over the past three periods registered -$74000.0, $183000.0, and $8.0 million for Q4 2012, Q3 2012, and Q4 2011 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Discontinued) (Qtr)
1 Johnson & Johnson 650.65 Bn 629.89 Bn 17.26 Bn -
2 AbbVie 466.34 Bn 459.82 Bn 12.70 Bn -
3 Merck 362.11 Bn 355.02 Bn 12.21 Bn -
4 Novartis Ag 267.81 Bn 260.52 Bn 11.24 Bn -
5 Pfizer 157.31 Bn 145.91 Bn 10.94 Bn 8.00 Mn
6 Bristol Myers Squibb 128.75 Bn 117.69 Bn 9.25 Bn -
7 Sanofi 51.80 Bn 44.84 Bn 10.79 Bn -
8 Revolution Medicines 40.91 Bn 40.91 Bn - -
9 BeOne Medicines 39.65 Bn 34.55 Bn 1.53 Bn -
10 Opko Health 1.25 Bn 945.61 Mn 80.02 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2012 -74,000.00
Sep 30, 2012 183,000.00
Dec 31, 2011 8.02 Mn
Sep 30, 2011 -1.49 Mn
Jun 30, 2011 -399,000.00
Mar 31, 2011 -955,000.00
Dec 31, 2010 -1.79 Mn
Sep 30, 2010 -2.52 Mn
API Access

Opko Health Income from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-discontinued-operations&ticker=OPK&period=max&api_key=YOUR_API_KEY